Dr. Jen Superpaste Ortho

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 2 years and older are instructed to brush their teeth twice daily using a pea-sized amount of the product for a duration of two minutes. After brushing, patients should spit out any excess product and refrain from rinsing. It is recommended to wait at least 30 minutes before eating or drinking, unless otherwise directed by a dentist or physician.

For children under 6 years of age, caregivers should provide guidance on proper brushing and spitting techniques to minimize the risk of swallowing the product. Supervision is advised until the child is capable of brushing without assistance. For children under 2 years of age, consultation with a dentist or physician is necessary prior to use.

The product is intended for oral use through brushing teeth, with administration occurring twice daily.

Contraindications

Use is contraindicated in children under 6 years of age. This precaution is necessary to prevent potential harm, as the safety and efficacy of the product have not been established in this age group. Additionally, it is advised to keep the product out of reach of children to avoid accidental ingestion or misuse.

Warnings and Precautions

Accidental ingestion of amounts exceeding the recommended dosage for brushing necessitates immediate medical attention. Healthcare professionals should advise patients to seek emergency medical help or contact a Poison Control Center without delay in such instances.

It is imperative to keep this product out of the reach of children under 6 years of age to prevent accidental ingestion. The potential risks associated with ingestion in this age group warrant strict supervision and appropriate storage measures.

Currently, there are no specific laboratory tests recommended for monitoring the safe use of this product. However, healthcare providers should remain vigilant and assess any adverse effects or complications that may arise from misuse or accidental ingestion.

In the absence of additional information regarding the cessation of use or further medical guidance, healthcare professionals are encouraged to maintain open communication with patients regarding any concerns or unusual symptoms that may develop.

Side Effects

Patients should be aware that if more than the recommended amount used for brushing is accidentally swallowed, it is imperative to seek medical assistance or contact a Poison Control Center immediately. This warning highlights the potential seriousness of accidental ingestion and underscores the importance of adhering to the recommended usage guidelines to prevent adverse outcomes.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Jen Superpaste Ortho (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be kept out of reach of the product. For children aged 2 years and older, it is recommended to brush teeth twice daily with a pea-sized amount of the product for two minutes, ensuring they spit out any excess and do not rinse. Patients should wait 30 minutes before eating or drinking, or follow the guidance of a dentist or doctor.

For children under 6 years, it is essential to instruct them in proper brushing and spitting techniques to minimize swallowing. Supervision is advised until the child is capable of brushing without assistance. For infants and children under 2 years of age, consultation with a dentist or doctor is recommended prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that there are no specific safety concerns or dosage modifications associated with the use of this medication during pregnancy as detailed in the prescribing information. Additionally, no special precautions regarding its use in pregnant individuals have been outlined. Healthcare professionals are encouraged to consider the overall clinical context when prescribing this medication to women of childbearing potential. As always, the benefits and risks should be carefully weighed in the context of individual patient circumstances.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is critical to seek immediate medical assistance or contact a Poison Control Center if an amount exceeding that typically used for brushing is accidentally ingested.

Healthcare professionals should be aware that prompt intervention is essential in managing potential overdosage scenarios. Symptoms may vary depending on the specific substance involved, and monitoring for adverse effects is recommended.

Management procedures should include supportive care and symptomatic treatment as necessary. It is advisable to have the product's labeling and any relevant patient information available when contacting medical professionals or poison control for guidance.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children under 6 years of age. It is important to emphasize the potential risks associated with accidental ingestion by young children and to encourage patients to store the medication in a secure location.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered orally, with a recommended regimen for adults and children aged 2 years and older to brush their teeth twice daily using a pea-sized amount for two minutes. Patients should spit out any excess and refrain from rinsing, waiting 30 minutes before eating or drinking, unless otherwise directed by a dentist or doctor.

Clinicians should advise parents to instruct children under 6 years in proper brushing and spitting techniques to reduce the risk of swallowing. Supervision is recommended until children are capable of brushing without assistance. For children under 2 years of age, consultation with a dentist or doctor is advised. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dr. Jen Superpaste Ortho, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)